| Delivery of chemotherapeutic drugs in tumour cell-derived microparticles K Tang, Y Zhang, H Zhang, P Xu, J Liu, J Ma, M Lv, D Li, F Katirai, ... Nature communications 3 (1), 1282, 2012 | 462 | 2012 |
| An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways M Lv, X Zhang, H Jia, D Li, B Zhang, H Zhang, M Hong, T Jiang, Q Jiang, ... Leukemia 26 (4), 769-777, 2012 | 221 | 2012 |
| Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model Z Yang, B Zhang, D Li, M Lv, C Huang, GX Shen, B Huang PloS one 5 (1), e8922, 2010 | 215 | 2010 |
| MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia H Ye, X Liu, M Lv, Y Wu, S Kuang, J Gong, P Yuan, Z Zhong, Q Li, H Jia, ... Nucleic acids research 40 (12), 5201-5214, 2012 | 152 | 2012 |
| SCF and IL‐31 rather than IL‐17 and BAFF are potential indicators in patients with allergic asthma Z Lei, G Liu, Q Huang, M Lv, R Zu, GM Zhang, ZH Feng, B Huang Allergy 63 (3), 327-332, 2008 | 148 | 2008 |
| Myeloid-derived suppressor cells in hematological malignancies: friends or foes M Lv, K Wang, X Huang Journal of Hematology & Oncology 12 (1), 105, 2019 | 119 | 2019 |
| Monocytic and promyelocytic myeloid‐derived suppressor cells may contribute to G‐CSF‐induced immune tolerance in haplo‐identical allogeneic hematopoietic stem cell transplantation M Lv, XS Zhao, Y Hu, YJ Chang, XY Zhao, Y Kong, XH Zhang, LP Xu, ... American Journal of Hematology 90 (1), E9-E16, 2015 | 84 | 2015 |
| Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go M Lv, XJ Huang Journal of hematology & oncology 5, 1-8, 2012 | 72 | 2012 |
| M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity HY Zhao, YY Zhang, T Xing, SQ Tang, Q Wen, ZS Lyu, M Lv, Y Wang, ... Signal transduction and targeted therapy 6 (1), 234, 2021 | 58 | 2021 |
| Preventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post‐transplantation minimal residual disease (MRD) monitoring and MRD … XD Mo, M Lv, XJ Huang British journal of haematology 179 (2), 184-197, 2017 | 58 | 2017 |
| TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b D Li, H Jia, H Zhang, M Lv, J Liu, Y Zhang, T Huang, B Huang Oncoimmunology 1 (5), 687-693, 2012 | 52 | 2012 |
| Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3 L Lin, F Yan, D Zhao, M Lv, X Liang, H Dai, X Qin, Y Zhang, J Hao, X Sun, ... Oncotarget 7 (9), 9844, 2016 | 49 | 2016 |
| Early myeloid-derived suppressor cells (HLA-DR−/lowCD33+CD16−) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease … K Wang, M Lv, YJ Chang, XY Zhao, XS Zhao, YY Zhang, YQ Sun, ... Journal of hematology & oncology 12, 1-16, 2019 | 47 | 2019 |
| Myeloablative haploidentical transplantation is superior to chemotherapy for patients with intermediate-risk acute myelogenous leukemia in first complete remission M Lv, Y Wang, YJ Chang, XH Zhang, LP Xu, Q Jiang, H Jiang, J Lu, ... Clinical Cancer Research 25 (6), 1737-1748, 2019 | 45 | 2019 |
| miRNA-98-5p targeting IGF2BP1 induces mesenchymal stem cell apoptosis by modulating PI3K/Akt and p53 in immune thrombocytopenia Y Wang, J Zhang, Y Su, C Wang, G Zhang, X Liu, Q Chen, M Lv, Y Chang, ... Molecular Therapy-Nucleic Acids 20, 764-776, 2020 | 42 | 2020 |
| Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation M Lv, Y Chang, X Huang Frontiers of Medicine 13, 45-56, 2019 | 42 | 2019 |
| An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study SQ Li, LP Xu, Y Wang, XH Zhang, H Chen, YH Chen, FR Wang, W Han, ... Blood, The Journal of the American Society of Hematology 140 (5), 516-520, 2022 | 39 | 2022 |
| Update of the “Beijing Protocol” haplo-identical hematopoietic stem cell transplantation M Lv, Y Chang, X Huang Bone marrow transplantation 54 (Suppl 2), 703-707, 2019 | 35 | 2019 |
| miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine-2, 3-dioxygenase X Zhao, Y Wang, M Lv, Y Kong, H Luo, X Ye, Q Wu, T Zhao, Y Hu, ... Oncotarget 7 (30), 48321, 2016 | 35 | 2016 |
| Quantity and quality reconstitution of NKG2A+ natural killer cells are associated with graft-versus-host disease after allogeneic hematopoietic cell transplantation LJ Hu, XY Zhao, XX Yu, M Lv, TT Han, W Han, XJ Huang Biology of Blood and Marrow Transplantation 25 (1), 1-11, 2019 | 32 | 2019 |
